New hope for advanced cancer? early trial of HF50 begins
Disease control
Not yet recruiting
This early-stage study tests a new drug called HF50 in about 45 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also watch for any signs that the drug shrinks tu…
Phase: PHASE1 • Sponsor: HighField Biopharmaceuticals Corporation • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC